NEURIZON THERAPEUTICS LIMITED (NUZ)

---

AI Coverage Rating: Low

ASX AI Signals has generated 0 signals for NUZ during the last 90 days, indicating low trading activity

NUZ Share Price
Current Price	$0.070
52 Week High	$0.167
52 Week Low:	$0.058
Trading at (% of 52 Week High)	41.92%

Business Overview

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biopharmaceutical company focused on developing treatments for neurological disorders, particularly Parkinson's disease. The company works on innovative therapies aimed at slowing or stopping disease progression.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

Latest  NEURIZON THERAPEUTICS LIMITED(NUZ)   News

03 Jul 2025, 07:00 PM

Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel

Elanco Animal Health (ELAN) has entered into an exclusive global licensing agreement with Neurizon T PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign

02 Jul 2025, 09:00 PM

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing data and out